← Open Payments lookup

BRANDY SANFORD: Open Payments

NPI 1114414158 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$199 in 11 payments from 8 companies in 2025. Trend: 2023 $127 · 2024 $190 · 2025 $199

Food & beverage: $199
CompanyPaymentsAmount
ABBVIE INC.2$40
Novo Nordisk Inc2$33
AstraZeneca Pharmaceuticals LP2$29
Otsuka America Pharmaceutical, Inc.1$24
SANOFI PASTEUR INC.1$23
Sumitomo Pharma America, Inc.1$21
Lilly USA, LLC1$16
Bayer Healthcare Pharmaceuticals Inc.1$14

Products named: QULIPTA, REXULTI, FLUZONE HIGH-DOSE, GEMTESA, Ozempic, Wegovy, MOUNJARO, AIRSUPRA.

Industry payments across NE — which companies pay providers there.